Dosage Matters: How Much Tongkat Ali Should You Take?

There is a deeply Singaporean tendency to believe that more is better. It surfaces in the way the city approaches education, career advancement, property investment, and, with predictable consistency, health supplementation. If one capsule of a supplement is good, the reasoning goes, surely two or three will be proportionally better. It is a logic that makes intuitive sense in a culture built on measurable output and incremental gains, and it is a logic that, when applied to bioactive herbal compounds with genuine hormonal mechanisms, can cause real physiological harm.

Tongkat Ali is not a vitamin. It is not a mineral supplement that the body will simply excrete in excess. It is a pharmacologically active botanical extract that modulates the hypothalamic-pituitary-adrenal and hypothalamic-pituitary-gonadal axes — two of the body’s most consequential endocrine regulatory systems. Used at the right dose, in the right context, with the right formulation, it has a compelling evidence base for cortisol reduction, testosterone optimisation, physical performance enhancement, and psychological wellbeing.

Used recklessly — at excessive doses, without regard for individual context, or in combination with contraindicated substances — it can produce a range of adverse outcomes that are not widely discussed in the enthusiastic social media discourse that has driven its mainstream popularity.

This article addresses that gap with the precision the subject demands. Dosage is not a footnote in the Tongkat Ali conversation. It is the conversation.

Understanding What You Are Actually Dosing

Before any meaningful discussion of dose can be had, a foundational distinction must be established: the difference between raw herb equivalent, crude extract, and standardised extract. These three categories are not interchangeable, and the failure to understand their differences is responsible for a substantial proportion of the confusion — and the inconsistency of outcomes — that characterises anecdotal reports of Tongkat Ali supplementation online.

Raw herb equivalent

A raw herb equivalent refers to the amount of whole dried root that a given capsule claims to represent. Products frequently label themselves as providing “5,000 mg” or even “20,000 mg” of Tongkat Ali root equivalent, figures that sound impressively substantial but convey almost nothing useful about how much bioactive eurycomanone, eurypeptides, or glycosaponins the consumer is actually receiving. The concentration of these bioactives in an unstandardised raw root varies enormously depending on the plant’s age, geographical origin, soil conditions, and post-harvest handling — factors that a label number cannot capture.

Crude extract

A crude extract is sometimes positioned as the next step up — produced by processing the root and expressing the result as a ratio such as 50:1, 100:1, or even 200:1, meaning that 50 kg, 100 kg, or 200 kg of raw root were used to yield 1 kg of finished extract. It is worth being honest about how this number actually functions in the supplement market: the extract ratio is largely marketing jargon, not a reliable potency indicator. Consumer intuition — that a higher ratio is better — runs in the wrong direction.

A 200:1 ratio means a large quantity of raw root was processed down into a small quantity of extract, which can just as easily reflect low-quality starting material, aggressive processing that destroys fragile bioactives, or simple over-concentration as it can reflect genuine potency. A 200:1 extract of poor source root can contain less active eurycomanone, glycosaponin, and bioactive peptide content per gram than a 20:1 extract of high-quality source root. Without a stated standardisation profile, the ratio tells the consumer almost nothing about what they are actually swallowing.

Standardised extract

A standardised extract is the only formulation category that provides genuine dosing precision. By defining the percentage of key bioactives — typically eurycomanone content, expressed as a percentage of extract weight — standardised extracts allow consistent, reproducible dosing that corresponds to the quantities used in published clinical trials.

Physta®, for instance, is produced at an extraction ratio in the region of 20:1 or less — deliberately, because its potency derives from a hot-water extraction process designed to preserve the full spectrum of water-soluble bioactives, then standardised to a defined eurycomanone, glycosaponin, and bioactive-peptide content (typically 0.8–1.5% eurycomanone, >40% glycosaponins, >22% total protein). Concentrating further would not increase potency; it would simply strip away the very compounds the extract is designed to deliver. The lesson for the consumer is that ratio and potency are not the same thing — and where they diverge, standardisation, not the headline ratio, is the figure to look for.

The Clinical Evidence Base for Safe Dosage Ranges

The most extensively studied standardised Tongkat Ali extract in the human clinical literature is Physta® — a freeze-dried hot water extract standardised to defined eurycomanone and glycosaponin content, developed through Malaysian government-funded research and the subject of multiple peer-reviewed RCTs. The dose range used across the majority of these studies is 200–400 mg daily of the Physta® extract, taken as a single daily dose — most commonly in the morning, either with or without food, though pre-workout and evening dosing both have credible evidence behind them and are discussed in more detail below.

Within that range, 200 mg is the most extensively replicated efficacious dose — repeatedly demonstrating statistically significant improvements in cortisol, testosterone, mood state, libido, and physical performance in healthy adults, moderately stressed individuals, and aging populations, consistently and without clinically meaningful adverse effects. 400 mg daily has also been formally studied (notably the 2014 Henkel trial in physically active seniors) and produced larger gains in muscle strength and free testosterone, suggesting that 200–400 mg is the well-evidenced daily window for standardised Tongkat Ali extract.

Studies have explored doses up to 400 mg daily in specific populations, including physically active older adults — the 2014 Henkel study, for instance, used 400 mg daily in men and women over 57 and reported significant improvements in muscle strength and hormonal parameters without adverse events. Subsequent Physta® research has extended the supportive evidence base to around 600 mg daily for shorter-term, cycled use, which now represents the upper clinical ceiling where published human data is still available. Together, these data points — 200–400 mg as the well-evidenced daily range, and up to 600 mg as the short-term cycled ceiling with supporting clinical evidence — define the therapeutic window for standardised Tongkat Ali extract in healthy adults.

What lies beyond 600 mg daily is, frankly, experimental territory. Doses above this clinical ceiling have not been the subject of well-designed long-term human RCTs, and their safety and efficacy profiles cannot be extrapolated from the available evidence.

This does not mean that higher doses are necessarily dangerous in the short term, but it does mean that anyone consuming significantly more than 600 mg of a standardised extract daily — particularly without cycling — is operating outside the envelope of what clinical science has validated. That is a distinction every informed Singaporean consumer deserves to understand before they follow a fitness influencer’s recommendation to “double up” for faster results.

Dosage by Gender: Why Men and Women Are Not the Same

The conversation about Tongkat Ali dosage cannot be gender-neutral, because the hormonal starting points of men and women are not equivalent, and the threshold at which androgenic stimulation shifts from beneficial to physiologically inappropriate differs significantly between the sexes.

Recommended dosage for men

For men — particularly those experiencing the cortisol-driven testosterone suppression that characterises the professional demographic most commonly encountered — the recommended daily range of a standardised extract is 200–400 mg, with 200 mg representing a well-calibrated starting point for most users. Men with documented testosterone in the low-normal range, or those engaged in regular resistance training with demanding recovery requirements, may titrate toward the upper end of that range (300–400 mg daily) after an initial four-to-six-week period at the lower dose, provided their response is monitored and no adverse effects emerge.

Shorter-term, cycled blocks at the upper clinical ceiling of around 600 mg daily are supported by published Physta® research, but should be reserved for specific training or recovery contexts and ideally undertaken with medical guidance. The hormonal environment of the adult male — with testosterone production occurring in the testes at physiological concentrations orders of magnitude above the female baseline — provides a broader safety margin for androgenic modulation.

Recommended dosage for women

For women, the dosing calculus is more conservative and the clinical guidance correspondingly more cautious. Women produce testosterone in the ovaries and adrenal glands at levels approximately ten to twenty times lower than men, meaning that equivalent absolute increases in circulating androgens represent proportionally larger percentage changes — and correspondingly greater risks of androgenic side effects including acne, hirsutism, and menstrual irregularity at excessive doses.

The limited clinical evidence available for women, including the 2014 Henkel study and pilot data from hormonal wellness researchers, suggests that 200 mg daily of a standardised extract is both the efficacious and the appropriate maximum for most women, with particularly cautious application warranted in premenopausal women with already-normal androgen levels.

Women with polycystic ovary syndrome (PCOS), who typically present with elevated androgens as a feature of their condition, should approach Tongkat Ali with specific clinical guidance from a qualified physician, as further androgenic stimulation is likely to exacerbate rather than ameliorate their hormonal profile. Conversely, postmenopausal women — for whom declining adrenal androgen production contributes meaningfully to fatigue, bone density loss, and reduced libido — may represent a population where even modest androgenic support at the 200 mg dose produces disproportionate benefit relative to risk. This is a hypothesis that deserves formal clinical investigation.

Dosage by Activity Level: The Athlete and the Sedentary Professional

Physical activity level is a meaningful modifier of both the optimal dose of Tongkat Ali and the pace at which outcomes are likely to manifest. Individuals engaged in regular resistance training or high-intensity sport experience greater cortisol elevation from training stress, greater androgen demand for muscle protein synthesis and recovery, and greater potential benefit from the herb’s dual stress-modulating and anabolic-supporting properties.

For this group, doses at the upper end of the evidence-supported range — 300 to 400 mg daily of a standardised extract for sustained use, with cycled blocks up to around 600 mg daily during demanding training phases — are more likely to be physiologically relevant, and the outcomes in terms of recovery speed, lean mass retention, and performance maintenance are more likely to be perceptible within the standard four-to-eight-week assessment window.

Bernard Lim, a 36-year-old competitive amateur triathlete from Serangoon who trains twelve to fifteen hours per week while managing a senior account director role, provides an instructive case study. He began with 200 mg of Physta® daily and, while noting modest improvements in his general mood and stress resilience, found the impact on his training recovery insufficient.

Under clinical guidance, he titrated to 400 mg daily over a twelve-week block and reported meaningfully faster recovery between sessions, improved training consistency, and a restoration of the competitive drive that overtraining-related cortisol accumulation had progressively eroded. His testosterone and cortisol panels at week twelve confirmed the hormonal improvement that his subjective experience had already indicated.

For sedentary individuals — the significant proportion of Singapore’s office-working population whose primary stressor is psychological rather than physical — 200 mg daily is typically both sufficient and optimal. The cortisol-modulating mechanism that is Tongkat Ali’s primary value for this group does not require higher doses to express meaningfully, and the principle of using the minimum effective dose is sound both clinically and philosophically.

Cycling Strategies: Why Continuous Use May Not Be Optimal

The most extensively studied standardised Tongkat Ali extract in the human clinical literature is Physta® — a freeze-dried hot water extract standardised to defined eurycomanone and glycosaponin content, developed through Malaysian government-funded research and the subject of multiple peer-reviewed RCTs. The dose range used across the majority of these studies is 200–400 mg daily of the Physta® extract, taken as a single daily dose — most commonly in the morning, either with or without food, though pre-workout and evening dosing both have credible evidence behind them and are discussed in more detail below.

Within that range, 200 mg is the most extensively replicated efficacious dose — repeatedly demonstrating statistically significant improvements in cortisol, testosterone, mood state, libido, and physical performance in healthy adults, moderately stressed individuals, and aging populations, consistently and without clinically meaningful adverse effects. 400 mg daily has also been formally studied (notably the 2014 Henkel trial in physically active seniors) and produced larger gains in muscle strength and free testosterone, suggesting that 200–400 mg is the well-evidenced daily window for standardised Tongkat Ali extract.

Studies have explored doses up to 400 mg daily in specific populations, including physically active older adults — the 2014 Henkel study, for instance, used 400 mg daily in men and women over 57 and reported significant improvements in muscle strength and hormonal parameters without adverse events. Subsequent Physta® research has extended the supportive evidence base to around 600 mg daily for shorter-term, cycled use, which now represents the upper clinical ceiling where published human data is still available. Together, these data points — 200–400 mg as the well-evidenced daily range, and up to 600 mg as the short-term cycled ceiling with supporting clinical evidence — define the therapeutic window for standardised Tongkat Ali extract in healthy adults.

What lies beyond 600 mg daily is, frankly, experimental territory. Doses above this clinical ceiling have not been the subject of well-designed long-term human RCTs, and their safety and efficacy profiles cannot be extrapolated from the available evidence.

This does not mean that higher doses are necessarily dangerous in the short term, but it does mean that anyone consuming significantly more than 600 mg of a standardised extract daily — particularly without cycling — is operating outside the envelope of what clinical science has validated. That is a distinction every informed Singaporean consumer deserves to understand before they follow a fitness influencer’s recommendation to “double up” for faster results.

Dosage by Gender: Why Men and Women Are Not the Same

The conversation about Tongkat Ali dosage cannot be gender-neutral, because the hormonal starting points of men and women are not equivalent, and the threshold at which androgenic stimulation shifts from beneficial to physiologically inappropriate differs significantly between the sexes.

Recommended dosage for men

For men — particularly those experiencing the cortisol-driven testosterone suppression that characterises the professional demographic most commonly encountered — the recommended daily range of a standardised extract is 200–400 mg, with 200 mg representing a well-calibrated starting point for most users. Men with documented testosterone in the low-normal range, or those engaged in regular resistance training with demanding recovery requirements, may titrate toward the upper end of that range (300–400 mg daily) after an initial four-to-six-week period at the lower dose, provided their response is monitored and no adverse effects emerge.

Shorter-term, cycled blocks at the upper clinical ceiling of around 600 mg daily are supported by published Physta® research, but should be reserved for specific training or recovery contexts and ideally undertaken with medical guidance. The hormonal environment of the adult male — with testosterone production occurring in the testes at physiological concentrations orders of magnitude above the female baseline — provides a broader safety margin for androgenic modulation.

Recommended dosage for women

For women, the dosing calculus is more conservative and the clinical guidance correspondingly more cautious. Women produce testosterone in the ovaries and adrenal glands at levels approximately ten to twenty times lower than men, meaning that equivalent absolute increases in circulating androgens represent proportionally larger percentage changes — and correspondingly greater risks of androgenic side effects including acne, hirsutism, and menstrual irregularity at excessive doses.

The limited clinical evidence available for women, including the 2014 Henkel study and pilot data from hormonal wellness researchers, suggests that 200 mg daily of a standardised extract is both the efficacious and the appropriate maximum for most women, with particularly cautious application warranted in premenopausal women with already-normal androgen levels.

Women with polycystic ovary syndrome (PCOS), who typically present with elevated androgens as a feature of their condition, should approach Tongkat Ali with specific clinical guidance from a qualified physician, as further androgenic stimulation is likely to exacerbate rather than ameliorate their hormonal profile. Conversely, postmenopausal women — for whom declining adrenal androgen production contributes meaningfully to fatigue, bone density loss, and reduced libido — may represent a population where even modest androgenic support at the 200 mg dose produces disproportionate benefit relative to risk. This is a hypothesis that deserves formal clinical investigation.

Dosage by Activity Level: The Athlete and the Sedentary Professional

Physical activity level is a meaningful modifier of both the optimal dose of Tongkat Ali and the pace at which outcomes are likely to manifest. Individuals engaged in regular resistance training or high-intensity sport experience greater cortisol elevation from training stress, greater androgen demand for muscle protein synthesis and recovery, and greater potential benefit from the herb’s dual stress-modulating and anabolic-supporting properties.

For this group, doses at the upper end of the evidence-supported range — 300 to 400 mg daily of a standardised extract for sustained use, with cycled blocks up to around 600 mg daily during demanding training phases — are more likely to be physiologically relevant, and the outcomes in terms of recovery speed, lean mass retention, and performance maintenance are more likely to be perceptible within the standard four-to-eight-week assessment window.

Bernard Lim, a 36-year-old competitive amateur triathlete from Serangoon who trains twelve to fifteen hours per week while managing a senior account director role, provides an instructive case study. He began with 200 mg of Physta® daily and, while noting modest improvements in his general mood and stress resilience, found the impact on his training recovery insufficient.

Under clinical guidance, he titrated to 400 mg daily over a twelve-week block and reported meaningfully faster recovery between sessions, improved training consistency, and a restoration of the competitive drive that overtraining-related cortisol accumulation had progressively eroded. His testosterone and cortisol panels at week twelve confirmed the hormonal improvement that his subjective experience had already indicated.

For sedentary individuals — the significant proportion of Singapore’s office-working population whose primary stressor is psychological rather than physical — 200 mg daily is typically both sufficient and optimal. The cortisol-modulating mechanism that is Tongkat Ali’s primary value for this group does not require higher doses to express meaningfully, and the principle of using the minimum effective dose is sound both clinically and philosophically.

Cycling Strategies: Why Continuous Use May Not Be Optimal

The concept of supplement cycling — alternating periods of use with periods of abstinence — is frequently discussed in the Tongkat Ali community but rarely explained with the mechanistic rigour that would help consumers make genuinely informed decisions about whether and how to cycle. The theoretical basis for cycling in the context of adaptogenic herbs rests on two concerns: the possibility of receptor downregulation over prolonged continuous stimulation, and the preservation of the body’s endogenous hormonal feedback mechanisms.

The HPA and HPG axes operate through negative feedback loops — systems where elevated downstream hormones signal upstream regulatory centres to reduce production. There is a theoretical concern, though not yet definitively demonstrated in long-term Tongkat Ali clinical trials, that sustained exogenous stimulation of these axes could attenuate the natural feedback sensitivity over time. Cycling is the precautionary response to this theoretical risk: by intermittently withdrawing the adaptogenic stimulus, the body’s own regulatory machinery is periodically left to operate unassisted, preserving its responsiveness.

The most commonly used cycling protocol in integrative clinical practice is a five-days-on, two-days-off weekly schedule, which provides consistent weekday supplementation while allowing a two-day hormonal “rest” over weekends. An alternative protocol used by some practitioners involves five weeks of continuous use followed by one week off — a monthly cycle that aligns with the four-to-six-week assessment windows used in most clinical research. It is simpler to maintain as a habit and avoids the hormonal fluctuation that some individuals experience during longer off-periods.

It is worth stating clearly that cycling protocols for Tongkat Ali remain in the realm of evidence-informed practice rather than definitively evidence-proven protocol. They represent the application of sound physiological reasoning to an area where long-term continuous-use data in humans is limited, and consumers should understand them as precautionary best practice rather than established fact.

The Risks of Overdosing: What Happens When More Becomes Too Much

The question of overdose risk with Tongkat Ali is one that the supplement’s enthusiastic marketing ecosystem systematically underemphasises, and it warrants direct, honest engagement. At doses significantly exceeding the clinical evidence range — particularly sustained use above the 600 mg clinical ceiling without cycling, or at any dose of an unstandardised crude product of unknown bioactive concentration — several adverse outcomes are physiologically plausible.

Excessive androgenic stimulation in men can drive testosterone into supraphysiological ranges that trigger compensatory estrogen conversion through aromatase activity, producing symptoms including water retention, mood volatility, and gynecomastia — an outcome deeply ironic for men taking the supplement for virilising purposes. In susceptible individuals, androgenic excess can also exacerbate benign prostatic hyperplasia (BPH) symptoms, accelerate androgenetic alopecia, and worsen oily skin and acne.

At the hepatic level, high-dose exposure to concentrated quassinoid compounds raises theoretical concerns about liver enzyme elevation, though published hepatotoxicity cases specifically attributable to pure, unadulterated standardised Tongkat Ali extract remain rare in the literature. The more significant hepatic risk is associated with adulterated products — those containing undeclared pharmaceuticals or other compounds — a risk that is a product quality issue rather than a Tongkat Ali-specific pharmacological concern, but one that consumers must remain vigilant about when dosing any supplement purchased through unverified channels.

It is also worth grounding this discussion in the formal toxicology literature, because the phrase “natural is safe” is rhetorical, not pharmacological. In published animal-model studies, the oral acute toxicity of standardised water-based Eurycoma longifolia extract — the same family of preparation as Physta® — has been reported with a median lethal dose (LD50) of approximately 3,000 mg/kg of body weight in rodents (Rehman, Choe, & Yoo, 2016; Li et al., 2013). For the powdered root, LD50 exceeded 6 g/kg with no acute deaths observed.

These animal figures do not translate directly to humans because of interspecies metabolic differences, but they do define the order-of-magnitude safety margin: even with conservative allometric scaling, a 70 kg adult would need to ingest tens of grams of standardised extract in a single dose to approach the toxicological threshold demonstrated in rats — many hundreds of times the 600 mg cycled clinical ceiling. Acute lethal toxicity in normal supplemental use is therefore exceedingly unlikely. The realistic risks at high human doses are not acute death but the chronic, endocrine, and hepatic concerns described above — which is precisely why dosing discipline matters even though the LD50 looks reassuringly distant on paper.

Vijay Krishnamurthy, a 48-year-old pharmacist at a restructured hospital in central Singapore, addressed this concern with characteristic precision during a pharmacist education session: “The dose makes the poison. That was true when Paracelsus said it in the 16th century and it is still the foundational principle of toxicology today. Tongkat Ali is not exempt from this principle because it is natural. Nothing is.”

His words carry a weight that every Singaporean consumer reaching for a Tongkat Ali product would do well to sit with — not as a deterrent to supplementation, but as an invitation to the kind of informed, measured approach that genuinely evidence-based self-care demands. The herb is remarkable. The science supporting its proper use is compelling. And the dose at which it delivers those outcomes is defined, reproducible, and well within the reach of any consumer willing to read beyond the front of the packaging.

Frequently Asked Questions

What is the recommended daily dosage of Tongkat Ali?

For most healthy adults, the recommended daily range of a standardised extract is 200–400 mg, taken as a single daily dose — most commonly in the morning, with or without food. Pre-workout (~30 minutes before training) and evening dosing are both also clinically supported alternatives — see the timing FAQ below for the trade-offs.

Within that range, 200 mg is the most extensively replicated dose across Physta® human RCTs — consistently showing meaningful improvements in cortisol, testosterone, mood, libido, and physical performance. 400 mg daily is supported by published trials in physically active and aging adults and is the upper end of the routinely-evidenced daily window. Most users do well starting at 200 mg and titrating up only if needed.

Can you take more than 600 mg of Tongkat Ali per day?

Around 600 mg daily of a standardised extract is the upper clinical ceiling where published Physta® research still supports use — specifically for shorter-term, cycled application rather than continuous daily intake. Doses above 600 mg are experimental: they have not been validated in well-designed long-term human RCTs, and sustained use at higher doses raises plausible concerns about excess androgenic activity, estrogen conversion, and other adverse outcomes. For everyday use, 200–400 mg daily is the well-evidenced range, with 200 mg the most-replicated starting dose.

Is the Tongkat Ali dosage the same for men and women?

No. Men typically respond well to 200–400 mg daily of a standardised extract, with the upper end reserved for athletes or those with low-normal testosterone. For women, 200 mg daily is both the efficacious and the appropriate maximum. Women with PCOS should consult a doctor before starting Tongkat Ali because their androgen profile may already be elevated.

What is the difference between raw, crude, and standardised Tongkat Ali extract?

A raw herb equivalent (e.g., “5,000 mg root”) tells you nothing about bioactive content. A crude extract is sold by ratio (50:1, 100:1, 200:1 — i.e. 100 kg or 200 kg of raw root yielding 1 kg of extract), and consumers often assume a higher ratio means a more potent product. The opposite is closer to the truth: extract ratios are largely marketing jargon, and a higher ratio frequently signals lower-quality source root or over-aggressive processing rather than greater potency.

A standardised extract specifies the percentage of key bioactives such as eurycomanone — this is the only category that allows precise, reproducible dosing matched to clinical research. Physta®, for example, sits at around a 20:1 extraction ratio because its potency comes from preserving and quantifying bioactives, not from headline concentration.

Should you cycle Tongkat Ali?

Cycling is a precautionary practice rather than a clinically mandated one. The two most-used protocols are five days on, two days off weekly, or five weeks on, one week off monthly. Cycling is intended to preserve the responsiveness of the body’s natural hormonal feedback loops over long-term use; the long-term data is still developing.

Can you overdose on Tongkat Ali?

Acute lethal overdose from a normal supplement bottle is exceedingly unlikely — the published oral LD50 of standardised water-based Tongkat Ali extract in rodents is approximately 3,000 mg/kg of body weight, with the powdered root exceeding 6 g/kg, which translates to a very large absolute safety margin over typical human doses. The realistic risk is not acute lethality but the consequences of sustained excess.

Risk rises sharply once you move past the 600 mg clinical ceiling without cycling, or use unstandardised products of unknown potency. Reported and plausible effects of sustained excess intake include androgenic over-stimulation, estrogen rebound (water retention, gynecomastia), worsening of BPH or acne, and — in adulterated products — possible hepatic effects. The dose range with the strongest safety and efficacy evidence is 200–400 mg daily for sustained use, with cycled blocks up to ~600 mg reserved for specific short-term contexts.

When should you take Tongkat Ali for best results?

There are three reasonable timing windows, each backed by its own line of evidence:

• In the morning (with or without food — Tongkat Ali does not require food for absorption, though some users find it gentler on the stomach when taken with a meal). Morning dosing aligns with the body’s natural cortisol-testosterone diurnal rhythm and is the timing used in the majority of published clinical trials.
• Roughly 30 minutes before exercise on training days. Pre-workout dosing leverages the herb’s cortisol-modulating and androgen-supporting effects through the session itself, and is favoured by athletes and active users.
• In the evening, which is generally well-tolerated and may carry an additional benefit: a randomised controlled trial in healthy Japanese adults (Toyama et al., 2022, Japanese Pharmacology & Therapeutics) found that four weeks of Tongkat Ali supplementation improved stress markers and sleep-quality scores measured on the Oguri-Shirakawa-Azumi sleep inventory. Older general advice to avoid evening use predates this evidence and is more conservative than the data now requires.

The one practical precaution: avoid taking Tongkat Ali too close to bedtime — within roughly an hour or two of sleep — particularly during the first couple of weeks of supplementation, while you observe how your own body responds. Individual sensitivity varies, and a small minority of users do find that very-late dosing can disrupt sleep onset even though the average effect on sleep quality across the wider population is favourable.

References

Hamzah, S., & Yusof, A. (2003). The ergogenic effects of Eurycoma longifolia Jack: A pilot study. British Journal of Sports Medicine, 37(5), 464–470. https://doi.org/10.1136/bjsm.37.5.464

Henkel, R. R., Wang, R., Bassett, S. H., Chen, T., Liu, N., Zhu, Y., & Tambi, M. I. M. (2014). Tongkat Ali as a potential herbal supplement for physically active male and female seniors: A pilot study. Phytotherapy Research, 28(4), 544–550. https://doi.org/10.1002/ptr.5017

Ismail, S. B., Wan Mohammad, W. M. Z., George, A., Nik Hussain, N. H., Musthapa Kamal, Z. M., & Liske, E. (2012). Randomised clinical trial on the use of PHYSTA® freeze-dried water extract of Eurycoma longifolia for the improvement of quality of life and sexual well-being in men. Evidence-Based Complementary and Alternative Medicine, 2012, 429268. https://doi.org/10.1155/2012/429268

Leisegang, K., Finelli, R., Sikka, S. C., & Iyer, S. (2022). Eurycoma longifolia (Jack) in men’s health: A review of its physiological, sexual, and ergogenic properties. Medicines, 9(5), 35. https://doi.org/10.3390/medicines9050035

Li, C. H., Liao, J. W., Liao, P. L., Huang, W. K., Tse, L. S., Lin, C. H., Kang, J. J., & Cheng, Y. W. (2013). Evaluation of acute 13-week subchronic toxicity and genotoxicity of the powdered root of Tongkat Ali (Eurycoma longifolia Jack). Evidence-Based Complementary and Alternative Medicine, 2013, 102987. https://doi.org/10.1155/2013/102987

Low, B. S., Das, P. K., & Chan, K. L. (2013). Standardized quassinoid-rich Eurycoma longifolia extract improved spermatogenesis and fertility in male rats via the hypothalamic-pituitary-gonadal axis. Journal of Ethnopharmacology, 145(3), 706–714. https://doi.org/10.1016/j.jep.2012.11.013

Rehman, S. U., Choe, K., & Yoo, H. H. (2016). Review on a traditional herbal medicine, Eurycoma longifolia Jack (Tongkat Ali): Its traditional uses, chemistry, evidence-based pharmacology and toxicology. Molecules, 21(3), 331. https://doi.org/10.3390/molecules21030331

Talbott, S. M., Talbott, J. A., George, A., & Pugh, M. (2013). Effect of Tongkat Ali on stress hormones and psychological mood state in moderately stressed subjects. Journal of the International Society of Sports Nutrition, 10(1), 28. https://doi.org/10.1186/1550-2783-10-28

Tambi, M. I. M., Imran, M. K., & Henkel, R. R. (2012). Standardised water-soluble extract of Eurycoma longifolia, Tongkat Ali, as testosterone booster for managing men with late-onset hypogonadism. Andrologia, 44(Suppl. 1), 226–230. https://doi.org/10.1111/j.1439-0272.2011.01168.x

Thu, H. E., Mohamed, I. N., Hussain, Z., Jayusman, P. A., & Shuid, A. N. (2017). Eurycoma longifolia as a potential alternative to testosterone for the treatment of male hypogonadism: A systematic review. Evidence-Based Complementary and Alternative Medicine, 2017, 3846029. https://doi.org/10.1155/2017/3846029

Toyama, H., Nakagawa, M., Iizuka, K., Kawatake, T., Toyama, T., & Tanaka, M. (2022). Randomized controlled trial of the effects of Tongkat Ali intake on stress markers and sleep quality in healthy Japanese adults. Japanese Pharmacology & Therapeutics, 50(5), 871. https://www.pieronline.jp/content/article/0386-3603/50050/871

Zanoli, P., & Zavatti, M. (2008). Pharmacognostic and pharmacological profile of Humulus lupulus L. Journal of Ethnopharmacology, 116(3), 383–396. https://doi.org/10.1016/j.jep.2008.01.011